PROTEGO PROMRI S 65
Report
- Report Number
- 1028232-2024-06011
- Event Type
- Malfunction
- Date Received
- November 18, 2024
- Date of Event
- November 12, 2024
- Report Date
- January 27, 2025
- Manufacturer
- BIOTRONIK SE & CO. KG
- Product Code
- NVY
- PMA / PMN Number
- P980023
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- IT
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
COMBINATION PRODUCT: YES. -AS OF TODAY, THE MEDICAL DEVICE IS NOT AVAILABLE FOR ANALYSIS, THEREFORE THE DEVICE ITSELF COULD NOT BE INVESTIGATED. THE ANALYSIS IS THUS BASED ON THE INSPECTION OF THE MANUFACTURING DOCUMENTS OF THE DEVICE AS WELL AS ON THE PROVIDED DATA. THE QUALITY DOCUMENTS ACCOMPANYING THE MANUFACTURING PROCESS FOR THIS DEVICE WERE RE-INVESTIGATED. ALL PRODUCTION STEPS WERE PERFORMED ACCORDINGLY, AND IN PARTICULAR THE FINAL ACCEPTANCE TEST PROVED THE DEVICE FUNCTIONS TO BE AS SPECIFIED. THE ANALYSIS OF THE PROVIDED IEGM EPISODES NO. 183 FROM NOVEMBER 01, 2024; 178 FROM OCTOBER 25, 2024; 177 FROM OCTOBER 18, 2024; 174 FROM SEPTEMBER 26, 2024; 167 FROM AUGUST 16, 2024 AND 162 FROM JULY 15, 2024 REVEALED ARTIFACTS ON THE FF AND RV CHANNEL, WHICH LED TO OVERSENSING. IN EPISODE NO. 162 THE OVERSENSING ALSO RESULTED IN AN ABORTED ICD CHARGING. IN SPITE OF THE AVAILABLE INFORMATION, NO CONCLUSION CAN BE DRAWN REGARDING THE ROOT CAUSE OF THE CLINICAL OBSERVATION. AN ANALYSIS OF THE LEAD ITSELF WOULD BE NECESSARY TO DETERMINE THE ROOT CAUSE. SHOULD ADDITIONAL INFORMATION OR THE DEVICE ITSELF BECOME AVAILABLE FOR ANALYSIS, THE INVESTIGATION WILL BE UPDATED.
COMBINATION PRODUCT: YES.
OVERSENSING WAS REPORTED ON THE VENTRICULAR CHANNEL. THE LEAD WAS CAPPED AND A NEW LEAD WAS IMPLANTED. THE ICD WAS REPLACED TOO WITH AN UPGRADING SYSTEM.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 2621280 | PROTEGO PROMRI S 65 | ICD LEAD | NVY | BIOTRONIK SE & CO. KG | 394099 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Hospitalization |